Close Menu

NEW YORK – Qiagen reported after the close of the market on Wednesday that its first quarter revenues grew 7 percent year over year, or up 9 percent at a constant exchange rate (CER).

For the three months ended March 31, Qiagen posted $372.1 million in revenues compared to $348.7 million in the year-ago period. It beat the analysts' average estimate of $344.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.